Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Patient Biosimilar'

Patient Biosimilar published presentations and documents on DocSlides.

PhAMA Position on Biosimilar Medicines

PhAMA Position on Biosimilar Medicines

  • celsa-spraggs
  • 0 Slides

Ms. Leah Goodman. Contents. Key Messages. An Over...

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

  • stefany-barnette
  • 0 Slides

OMIC Group Biosimilars 2014. Hyderabad India. 27-...

MODULE 8. Follow-on drugs: generic, biosimilar

MODULE 8. Follow-on drugs: generic, biosimilar

  • alida-meadow
  • 0 Slides

& non-biological similar medicinal products ....

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • danika-pritchard
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • aaron
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

U.S. Biosimilars: An Introduction

U.S. Biosimilars: An Introduction

  • calandra-battersby
  • 0 Slides

Disclaimers. :. By 2016, 7 of the top 10 pharmace...

Comparison of US/EU Biosimilar

Comparison of US/EU Biosimilar

  • myesha-ticknor
  • 0 Slides

Guidelines. Kamali Chance, MPH, PhD, RAC. Senior...

Biosimilar Biological Products

Biosimilar Biological Products

  • luanne-stotts
  • 0 Slides

2016 . Clinical Investigator . Training Course. S...

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

  • calandra-battersby
  • 0 Slides

OMIC Group Biosimilars 2014. Hyderabad India. 27-...

The generic and biosimilar

The generic and biosimilar

  • alida-meadow
  • 0 Slides

perspective. Warwick Smith. Director General BGMA...

United Spinal Association

United Spinal Association

  • alida-meadow
  • 0 Slides

August, 2014. Biologics & Biosimilars: . An O...

Application of Biosimilars in RA IN Clinical Practice:

Application of Biosimilars in RA IN Clinical Practice:

  • conchita-marotz
  • 0 Slides

Key Issues and Challenges.  . Introduction. Diff...

Biosimilars in the united states – Update on FDA Impleme

Biosimilars in the united states – Update on FDA Impleme

  • test
  • 37 Slides

James C. Shehan. Hyman, Phelps & McNamara, P....

What You Need to Know About

What You Need to Know About

  • marina-yarberry
  • 17 Slides

Biosimilars. : Products, Recent Deals, IP Issues ...

Is Australia ready for

Is Australia ready for

  • liane-varnes
  • 12 Slides

biosimilar. . ?. David Lim, Julie Hepworth, Lis...

Phil Johnson MS

Phil Johnson MS

  • stefany-barnette
  • 56 Slides

RPh. Safe School Meds, Principle Partner. Moffitt...

Acceptable changes in quality attributes of glycosylated bi

Acceptable changes in quality attributes of glycosylated bi

  • debby-jeon
  • 19 Slides

Schiestl M, Stangler T, Torella C, et al. . Nat B...

Biosimilars

Biosimilars

  • lindy-dunigan
  • 22 Slides

Knowledge Connect Slide Resource. This slide dec...

Biosimilars in RA: A Blessing or a Curse?

Biosimilars in RA: A Blessing or a Curse?

  • conchita-marotz
  • 0 Slides

Introduction/Overview . What Is a Biosimilar?. Di...

Concurrent Session 1B

Concurrent Session 1B

  • yoshiko-marsland
  • 0 Slides

View . from the Life Sciences . Industry. Moderat...

US Regulatory Pathway For Biosimilars

US Regulatory Pathway For Biosimilars

  • cheryl-pisano
  • 0 Slides

Practical Legal/Regulatory Considerations Arising...

Biosimilars in the Real World

Biosimilars in the Real World

  • liane-varnes
  • 0 Slides

Introduction/Overview . PLANETRA Extension Study:...

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

Challenges in demonstrating biosimilarity and interchangeability of biosimilar products

  • calandra-battersby
  • 0 Slides

OMICS Group Biosimilars 2015 Birmingham, UK. 10-1...

Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives

Analytical Similarity Assessment: Practical Challenges and Statistical Perspectives

  • alida-meadow
  • 0 Slides

Richard Montes, Ph.D.. Hospira. , a Pfizer compan...

Understanding Biologics Biologics and Biosimilars

Understanding Biologics Biologics and Biosimilars

  • calandra-battersby
  • 0 Slides

Animation: What Are Biologics?. Production of Bio...

Biological Products: concepts, naming,

Biological Products: concepts, naming,

  • faustina-dinatale
  • 0 Slides

interchangeability,extrapolation. and safety. Dr...

Faculty Leonard H. Calabrese, DO

Faculty Leonard H. Calabrese, DO

  • trish-goza
  • 0 Slides

Professor of Medicine. Cleveland Clinic Lerner Co...

Applying Biosimilars in Hematologic Cancers

Applying Biosimilars in Hematologic Cancers

  • conchita-marotz
  • 0 Slides

This program will include a discussion of off-lab...

Phil Johnson MS RPh Safe School Meds, Principle Partner

Phil Johnson MS RPh Safe School Meds, Principle Partner

  • yoshiko-marsland
  • 0 Slides

Moffitt Cancer Center, Director of Pharmacy (Reti...

22 MayEMACHMPBWP2477132012Committee for Medicinal Products for Hum

22 MayEMACHMPBWP2477132012Committee for Medicinal Products for Hum

  • carla
  • 9 Slides

Adoption by CHMP for release for consultation24 Ma...

INSIGHTS INTO THE MARKET

INSIGHTS INTO THE MARKET

  • summer
  • 20 Slides

FOR INFLIXIMABTable of ContentsThe Evolving Landsc...

Budget impact and cost-effectiveness of oncology

Budget impact and cost-effectiveness of oncology

  • roxanne
  • 14 Slides

biosimilars. Prof. dr. Steven Simoens. Health econ...

  What is the value of Real-World Evidence for Biosimilars?

  What is the value of Real-World Evidence for Biosimilars?

  • bitsy
  • 82 Slides

Disclaimer. This panel is moderated by Dr. Delphin...

Category 1: Defining Terms

Category 1: Defining Terms

  • jasmine
  • 76 Slides

Clue: . A biologic product with no clinically mean...

JMP for Biosimilars : Tools for Analytical Similarity

JMP for Biosimilars : Tools for Analytical Similarity

  • erica
  • 26 Slides

Sept 16, 2015. W. Heath Rushing, . Adsurgo. LLC. ...

ASBM Biosimilars US Prescribers and Biosimilars Naming

ASBM Biosimilars US Prescribers and Biosimilars Naming

  • min-jolicoeur
  • 0 Slides

Kevin Olson, CEO. Industry Standard Research. Kev...

Latin American Physician Perspectives on Biosimilars

Latin American Physician Perspectives on Biosimilars

  • celsa-spraggs
  • 0 Slides

Presented at the . Latin American Biologics/Biosi...

Prescription Drug Resource Center

Prescription Drug Resource Center

  • roberts
  • 4 Slides

Generic Drug Substitution Laws May 3 , 2019 Compi...

FDA Approves First Biosimilar Sandozs Zarxio By Jennif

FDA Approves First Biosimilar Sandozs Zarxio By Jennif

  • pamella-moone
  • 2 Slides

Dienes Maria E Doukas Christopher J Betti PhD ...

A QUM partnership approach to regulating

A QUM partnership approach to regulating

  • liane-varnes
  • 18 Slides

biosimilars. in Australia. David Lim, Evan Siege...

Copyright © 2024 DocSlides. All Rights Reserved